| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
caspase 1 | 0.413 | 0.885 | 3.5E-05 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
collagen type XVIII alpha 1 chain | 0.449 | 0.808 | 1.7E-10 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | 0.482 | 0.846 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1967 | 1967 | ||||||||
|
carbonic anhydrase 9 | 0.483 | 0.731 | 1.3E-09 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
thymidylate synthetase | 0.425 | 0.846 | 0.72 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2014 | ||||||||
|
thrombospondin 1 | 0.407 | 0.885 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
retinoid X receptor alpha | 0.543 | 0.769 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
keratin 7 | 0.463 | 0.808 | 3.1E-12 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1995 | 1995 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
interleukin 18 binding protein | 0.603 | 0.731 | 1.5E-08 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
F-box protein 10 | 0.861 | 0.154 | 2.4E-06 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
poly(ADP-ribose) polymerase 1 | 0.389 | 0.923 | 3.3E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
FERM and PDZ domain containing 1 | 0.805 | 0.154 | 2.2E-12 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
fibroblast growth factor 10 | 0.530 | 0.692 | 0.94 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
erythropoietin receptor | 0.526 | 0.692 | 1.0E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
erythropoietin | 0.381 | 0.885 | 1.1E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
angiotensin II receptor type 1 | 0.423 | 0.846 | 5.3E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1993 | 2008 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
DNA methyltransferase 3 beta | 0.453 | 0.846 | 0.20 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
iodothyronine deiodinase 1 | 0.638 | 0.769 | 0.58 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
casein kinase 2 alpha 1 | 0.597 | 0.731 | 0.99 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
thioredoxin interacting protein | 0.490 | 0.731 | 0.16 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 |